MoneyWorks4Me

Sandu Pharmaceuticals informs about issuance of duplicate share certificate

08 Jun 2021 Evaluate

Pursuant to the regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Sandu Pharmaceuticals has informed that Linkintime India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares for Shareholder, Sunil Toshnival (Folio No: S03921), further details regarding the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..